Compass Therapeutics (CMPX) Return on Invested Capital (2020 - 2022)
Compass Therapeutics (CMPX) posted Return on Invested Capital of 0.09% for Q2 2022, down 109.68% sequentially from 0.04% in Q1 2022.
Compass Therapeutics (CMPX) Return on Invested Capital (2020 - 2022) Analysis & Trends
Compass Therapeutics has reported Return on Invested Capital for 3 years, with the latest figure at 0.09% in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -0.05% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.35% |
| 10 | Compass Therapeutics | 405.20 Mn | 405.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -0.09% |
| Mar 31, 2022 | -0.04% |
| Dec 31, 2021 | -0.03% |
| Sep 30, 2021 | -0.02% |
| Mar 31, 2021 | -0.02% |
| Sep 30, 2020 | -0.02% |
| Jun 30, 2020 | -0.05% |